Finally, among patients with WR‐, SN‐, and LN‐DLBCL, 4 (14%), 0 (0%), and 9 (20%) (p = 0.662) and 1 (4%), 0 (0%), and 2 (4%) had positive p53 and CD5 protein expression, respectively. The gene discussed is CD5; the disease is diffuse large B-cell lymphoma.